🔗 Share this article

Treasury head Rachel Reeves has revealed she is planning "focused steps to deal with household expense pressures" in the forthcoming Budget.

In comments to the BBC, she stated that reducing price rises is a joint duty of both the government and the Bank of England.

The United Kingdom's inflation rate is forecast to be the highest among the Group of Seven industrialized countries this year and the following year.

Potential Energy Bill Interventions

Reports indicate the government could take action to reduce energy bills, such as by reducing the current 5% rate of VAT applied on energy.

Another option is to cut some of the regulatory levies presently added to bills.

Fiscal Limitations and Analyst Predictions

The government will receive the next report from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will reveal how much room there is for such measures.

The view from the majority of experts is that Reeves will have to introduce tax rises or budget cuts in order to fulfill her declared borrowing rules.

Previously on Thursday, analysis indicated there was a twenty-two billion pound deficit for the Treasury chief to address, which is at the lower end of forecasts.

"There's a joint job between the Bank of England and the administration to further reduce some of the causes of inflation," the Chancellor stated to the BBC in Washington, at the annual meetings of the IMF and World Bank.

Revenue Commitments and International Concerns

While much of the focus has been on probable tax rises, the chancellor said the most recent data from the fiscal watchdog had not changed her pledge to election pledges not to increase tax levels on earnings tax, VAT or National Insurance.

She attributed an "unpredictable world" with growing geopolitical and commercial tensions for the Budget tax moves, probably to be targeted on those "wealthiest."

Global Trade Disputes

Commenting on concerns about the UK's trade ties with China she said: "The UK's national security always take priority."

Recent declaration by China to tighten export controls on rare earths and other resources that are crucial for high-technology production led US President Donald Trump to threaten an extra 100% tariff on imports from China, raising the risk of an full-scale commercial conflict between the two economic giants.

The American finance chief labeled China's move "commercial pressure" and "a international production control attempt."

Questioned on accepting the US offer to join its battle with China, the Chancellor said she was "deeply worried" by China's actions and called on the Chinese government "not to put up barriers and limit trade."

She said the decision was "harmful for the international commerce and causes additional headwinds."

"I believe there are fields where we should challenge China, but there are also significant opportunities to sell into China's economy, including financial services and other sectors of the economic system. We've got to achieve that balance right."

The chancellor also affirmed she was cooperating with international partners "regarding our own critical minerals strategy, so that we are less reliant."

NHS Medicine Costs and Investment

Reeves also admitted that the cost the NHS pays for medicines could rise as a consequence of current negotiations with the US government and its drugs companies, in return for reduced taxes and funding.

Some of the world's largest pharmaceutical manufacturers have said recently that they are either halting or abandoning projects in the UK, with several blaming the insufficient payments they are obtaining.

Last month, the government science advisor said the price the health service spends on drugs would have to increase to halt businesses and pharmaceutical investment departing from the United Kingdom.

The Chancellor told media: "We have seen as a result of the payment system, that drug testing, recent pharmaceuticals have not been available in the UK in the extent that they are in other continental states."

"The objective is to guarantee that patients getting care from the NHS are can obtain the finest essential treatments in the globe. And so we are examining these issues, and... aiming to secure additional investment into the UK."